Aaron Lerner received his MD, Ph.D. degree from the University and went on to an outstanding research and teaching career at the Yale School of Medicine specializing in the metabolic basis of inherited disease, specifically vitilego.
The focus on this seminar series is on the linkage between human disease and biochemical mechanisms.
Dr. Karen Ashe
University of Minnesota, Twin Cities
Department of Neurology
Tuesday, November 17th, 2009
12:20 PM in Mayo Auditorium
"Human relevance of a common Alzheimer mourse model."
|Dr. Berhnhard Hering, Dept. Surgery, University of Minnesota||Transformative Therapeutics to Cure Type 1 Diabetes.|
|Dr. Harry "Chip" Davis, Schering-Plough Research Institute, Kenilworth, NJ||Zetia (Ezetimibe): Inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to Reduce Intestinal Cholesterol Absorption and Treat Hyperlipidemia.|
|Dr. Michael Jensen|
Mayo Clinic, Rochester, MN
|Role of Adipose Tissue Fatty Acid Release in Human Metabolic Disease.|
|Dr. Arnold W. Strauss, MD|
Vanderbilt University, Nashville, TN
|Dr. Jean Schaffer|
Washington Univeristy School of Medicine, St. Louis, MO
|Lipotoxicity: when tissues overeat.|
|Dr. Paul Watkins|
Johns Hopkins School of Medicine, Baltimore, MD
|X-linked Adrenoleukodystrophy: Is there a problem with 'Bubblegum" in the Brain?|
|Dr. Vincent J. Hearing|
National Cancer Institute, Bethesda, MD
|Mechanisms of Hypopigmentation in Human Hypopigmentary Diseases.|